Skip to Main Content

Author Details

Margaret A Tucker
National Cancer Institute
1976
380
93
PMIDPaper TitleJournal TitlePublished Year
36876055Association of germline variants in telomere maintenance genes (<i>POT1, TERF2IP, ACD,</i> and <i>TERT</i>) with spitzoid morphology in familial melanoma: A multi-center case series.JAAD Int2023
37585199Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.JAMA Dermatol2023
36876055Association of germline variants in telomere maintenance genes (<i>POT1, TERF2IP, ACD,</i> and <i>TERT</i>) with spitzoid morphology in familial melanoma: A multi-center case series.JAAD Int2023
36787739Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding.Am J Hum Genet2023
37585199Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.JAMA Dermatol2023
36787739Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding.Am J Hum Genet2023
35174864Reproductive factors, hormone use, and incidence of melanoma in a cohort of US Radiologic Technologists.Hum Reprod2022
35902885Use of Nonsteroidal Anti-Inflammatory Drugs and Incidence of Melanoma in the United States Radiologic Technologists Study.Cancer Prev Res (Phila)2022
36269225Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant Carriers.JNCI Cancer Spectr2022
36201196Pooled Analysis of Meningioma Risk Following Treatment for Childhood Cancer.JAMA Oncol2022
36409970Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in <i>CDKN2A</i> and Pancreatic Cancer.JCO Precis Oncol2022
35315916Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults.JAMA Netw Open2022
34906508Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma.Genet Med2022
35174864Reproductive factors, hormone use, and incidence of melanoma in a cohort of US Radiologic Technologists.Hum Reprod2022
35181301Integrated Analysis of Coexpression and Exome Sequencing to Prioritize Susceptibility Genes for Familial Cutaneous Melanoma.J Invest Dermatol2022
36409970Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in <i>CDKN2A</i> and Pancreatic Cancer.JCO Precis Oncol2022
35902885Use of Nonsteroidal Anti-Inflammatory Drugs and Incidence of Melanoma in the United States Radiologic Technologists Study.Cancer Prev Res (Phila)2022
36269225Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant Carriers.JNCI Cancer Spectr2022
36201196Pooled Analysis of Meningioma Risk Following Treatment for Childhood Cancer.JAMA Oncol2022
35315916Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults.JAMA Netw Open2022
35181301Integrated Analysis of Coexpression and Exome Sequencing to Prioritize Susceptibility Genes for Familial Cutaneous Melanoma.J Invest Dermatol2022
34906508Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma.Genet Med2022
32907843Sebaceous Carcinoma Epidemiology and Genetics: Emerging Concepts and Clinical Implications for Screening, Prevention, and Treatment.Clin Cancer Res2021
33811164The Impact of Longitudinal Surveillance on Tumor Thickness for Melanoma-Prone Families with and without Pathogenic Germline Variants of <i>CDKN2A</i> and <i>CDK4</i>.Cancer Epidemiol Biomarkers Prev2021
33473166Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.Br J Cancer2021
33837776Genotypic vs Phenotypic Risk Assessment for Melanoma.J Natl Cancer Inst2021
34153328Increased Risk of Skin Cancer in 1,851 Long-Term Retinoblastoma Survivors.J Invest Dermatol2021
34262154Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.Genet Med2021
33713608Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry.Am J Hum Genet2021
34308104Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.JNCI Cancer Spectr2021
33917779Benign Tumors in Long-Term Survivors of Retinoblastoma.Cancers (Basel)2021
32907843Sebaceous Carcinoma Epidemiology and Genetics: Emerging Concepts and Clinical Implications for Screening, Prevention, and Treatment.Clin Cancer Res2021
33105035Role of radiotherapy and chemotherapy in the risk of leukemia after childhood cancer: An international pooled analysis.Int J Cancer2021
33713608Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry.Am J Hum Genet2021
33811164The Impact of Longitudinal Surveillance on Tumor Thickness for Melanoma-Prone Families with and without Pathogenic Germline Variants of <i>CDKN2A</i> and <i>CDK4</i>.Cancer Epidemiol Biomarkers Prev2021
33917779Benign Tumors in Long-Term Survivors of Retinoblastoma.Cancers (Basel)2021
33837776Genotypic vs Phenotypic Risk Assessment for Melanoma.J Natl Cancer Inst2021
34153328Increased Risk of Skin Cancer in 1,851 Long-Term Retinoblastoma Survivors.J Invest Dermatol2021
34262154Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.Genet Med2021
34308104Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.JNCI Cancer Spectr2021
33105035Role of radiotherapy and chemotherapy in the risk of leukemia after childhood cancer: An international pooled analysis.Int J Cancer2021
33473166Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.Br J Cancer2021
31326397Variation in Cutaneous Patterns of Melanomagenesis According to Germline CDKN2A/CDK4 Status in Melanoma-Prone Families.J Invest Dermatol2020
32422154Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma.Ophthalmology2020
32191290Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.JAMA Oncol2020
31794291Comparison of Radiation Dose Reconstruction Methods to Investigate Late Adverse Effects of Radiotherapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study.Radiat Res2020
32246964Ambient ultraviolet radiation and major salivary gland cancer in the United States.J Am Acad Dermatol2020
32283231Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain.J Am Acad Dermatol2020
31654664Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation.J Am Acad Dermatol2020
32881892Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma.PLoS One2020
  • 1 - 50 of 760

Recommended Authors

University of Colorado Anschutz Medical Campus
Career Start Year 2008
Number of shared co-authors 5
Sestre milosrdnice University Hospital Centre
Career Start Year 2005
Number of shared co-authors 1
University of Minnesota
Career Start Year 2004
Number of shared co-authors 19
Tufts Medical Center
Career Start Year 2004
Number of shared co-authors 1
Population Health Sciences Institute, Newcastle University
Career Start Year 2004
Number of shared co-authors 5
Vanderbilt University Medical Center
Career Start Year 2003
Number of shared co-authors 1
Moffitt Cancer Center
Career Start Year 2001
Number of shared co-authors 5
1Rijnstate Hospital
Career Start Year 2001
Number of shared co-authors 0
University of California san francisco
Career Start Year 1998
Number of shared co-authors 2
Novartis Pharmaceuticals
Career Start Year 1995
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 1992
Number of shared co-authors 8
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 72
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Career Start Year 1991
Number of shared co-authors 68
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 33
Stanford University
Career Start Year 1989
Number of shared co-authors 10
University of California irvine
Career Start Year 1988
Number of shared co-authors 87
CancerLinQ LLC, American Society of Clinical Oncology
Career Start Year 1987
Number of shared co-authors 27
Wellcome Sanger Institute
Career Start Year 1987
Number of shared co-authors 60
Frazer Institute, The University of Queensland, Dermatology Research Centre
Career Start Year 1985
Number of shared co-authors 20
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 18
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 7
Saint John's Cancer Institute at Saint John's Health Center
Career Start Year 1982
Number of shared co-authors 4
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 36
National Cancer Institute, 9609 Medical Center Dr
Career Start Year 1981
Number of shared co-authors 79
University of Utah
Career Start Year 1980
Number of shared co-authors 74
Pomeranian Medical University
Career Start Year 1979
Number of shared co-authors 106
Mayo Clinic
Career Start Year 1978
Number of shared co-authors 81
University of Washington
Career Start Year 1975
Number of shared co-authors 28
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Career Start Year 1972
Number of shared co-authors 7
Ospedale Circolo e Fondazione Macchi
Career Start Year 1969
Number of shared co-authors 77

Collaborators

National Cancer Institute, National Institutes of Health
Co-authored papers 84
Frederick National Laboratory for Cancer Research
Co-authored papers 62
National Cancer Institute
Co-authored papers 57
National Cancer Institute, National Institutes of Health
Co-authored papers 56
National Cancer Institute
Co-authored papers 47
National Cancer Institute
Co-authored papers 42
National Cancer Institute
Co-authored papers 39
St Jude Children's Research Hospital
Co-authored papers 37
National Cancer Institute
Co-authored papers 37
Co-authored papers 33
National Cancer Institute.
Co-authored papers 27
Co-authored papers 27
Co-authored papers 25
National Cancer Institute, Frederick National Laboratory for Cancer Research
Co-authored papers 24
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 24
Co-authored papers 22
Frederick National Laboratory for Cancer Research
Co-authored papers 21
National Cancer Institute
Co-authored papers 19
Co-authored papers 19
Clinical Genetics Branch, National Cancer Institute (NCI)
Co-authored papers 19
Harvard T. H. Chan School of Public Health
Co-authored papers 19
Co-authored papers 19
The Kolling Institute, University of Sydney, and Royal North Shore Hospital
Co-authored papers 19
Co-authored papers 19
Boston Children's Hospital and Harvard Medical School
Co-authored papers 18
QIMR Berghofer Medical Research Institute
Co-authored papers 18
Co-authored papers 17
Co-authored papers 17
University of Southern California
Co-authored papers 16
University of Massachusetts Chan Medical School
Co-authored papers 15